Factor Biosciences Therapeutics

Factor Biosciences Therapeutics was an Ireland-based biotechnology company entity associated with Factor Bioscience and used in licensing transactions around the group’s cell-engineering technology portfolio. Public disclosures indicate it licensed mRNA-based cell reprogramming and gene-editing technologies for development of engineered cell therapies, including programs relevant to cancer, blood disorders, and monogenic diseases. The company appears to have functioned primarily as a technology-holding and licensing vehicle rather than as a standalone commercial operating company with a broad independently disclosed pipeline. Factor Bioscience today presents itself under the broader Factor Bioscience brand, focused on mRNA, gene editing, cell reprogramming, nucleic acid delivery, and advanced cell therapies. Based on available public information, Factor Biosciences Therapeutics itself does not appear to be an active standalone operating company as of 2026.